New horizons in predictive drug metabolism and pharmacokinetics
نام عام مواد
[Book]
نام نخستين پديدآور
edited by Alan G.E. Wilson.
وضعیت نشر و پخش و غیره
محل نشرو پخش و غیره
Cambridge, UK
نام ناشر، پخش کننده و غيره
Royal Society of Chemistry, [
تاریخ نشرو بخش و غیره
2016]
مشخصات ظاهری
نام خاص و کميت اثر
(xxi, 422 pages .).
فروست
عنوان فروست
RSC drug discovery series.
یادداشتهای مربوط به مندرجات
متن يادداشت
How physicochemical properties of drugs affect their metabolism and clearance; Role of solubility, permeability and adsorption in drug discovery in development; Models for nonspecific binding and partitioning; Cytochrome P450 mediated drug metabolism; Non-cytochrome P450 enzymes and glucuronidation; Metabolite profiling; Application of humanised and other transgenic models to predict human responses to drugs; Stem cells and drug metabolism; Chemically reactive versus stable drug metabolites: Role in adverse drug reactions; Integrating metabolism and toxicity properties; Metabolomics-based approaches to determine drug metabolite profiles; Drug-drug ineteractions: regulatory and theoretical considerations, and an industrial perspective; Drug-drug interactions: Computational approaches; Induction of hepatic cytochrome P450 enzymes: Importance in drug development and toxicity; Current status and implications of transporters: QSAR analysis method to evaluate drug-drug interactions of human bile salt export pump (ABCB11/BSEP) and prediction of intrahepatic cholestasis risk; Formulation of optimizing bioavailability; Systems pharmacology modelling; Pharmacokinetic-pharmacodynamic modelling in drug development with special reference to oncology;
موضوع (اسم عام یاعبارت اسمی عام)
موضوع مستند نشده
Drug development.
موضوع مستند نشده
Drugs -- Metabolism.
موضوع مستند نشده
Pharmacokinetics.
رده بندی کنگره
شماره رده
RM301
.
55
نشانه اثر
E358
2016
نام شخص به منزله سر شناسه - (مسئولیت معنوی درجه اول )